| | 
Part, Chapter, Paragraph
1 II, 5. 4. 8 | Pediatr Diabetes 8(3):117-37~Waug A (2007): Screening
2 II, 5. 5.Int(12)| School of Public Health, 117-135).~
3 II, 5. 5. 3 | Psychiatry Clin Neurosci 254(2):117-28.~Healy D, Harris M, Tranter
4 II, 5. 5. 3 | study. Mult Scler 7:111-117.~McGuigan C, McCarthy A,
5 II, 5. 5. 3 | Neurological Sciences 22:117-140.~Rose AS, Ellison GW,
6 II, 5. 6. 6 | arthritis. Ann Intern Med 117:801-806~Woolf AD (2000):
7 II, 5. 8. 7 | definition. Chest 2000; 117: 339S-345S.~ ~Viegi G, Mattelli
8 II, 5. 9. 7 | perspective. J Laryngol Otol. Dec;117(12):946-50.~ ~L I (2008):
9 III, 10. 1. 3 | measurement. J Drug Educ 28(2):117-134.~Marcus BH, Williams
10 III, 10. 2. 1 | and obesity. Pediatrics, ,117(2):417-424.Harro M et al. (
11 III, 10. 4. 2 | by Council Directive 92/117/ECC. This Directive required
12 III, 10. 4. 2 | basis. As in Directive 92/117, the requirement to monitor
13 III, 10. 4. 2(29)| repealing Council Directive 92/117/EEC(OJ L 325,12.12.2003
14 III, 10. 4. 2 | European Communities No. L 117, 8 May 1990. Available at:~htt ~ ~
15 IV, 12. 10 | Planning”~o Presidential Degree 117/2004 Measures, terms and
16 IV, 12. 10 | the Presidential Decree 117/2004.~ ~Hellenic Recovery
17 IV, 12. 10 | according to the directions 75/117 and 76/207 of the EU.~o
|
|
| |
